ArticleFrontiers in immunology2021

Bispecific Antibody PD-L1 x CD3 Boosts the Anti-Tumor Potency of the Expanded Vγ2Vδ2 T Cells.

Rui Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.